← Eichor
Condition: Breast Cancer Female Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Breast Cancer Female

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04778839Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT07416630a Single-arm, Single-center, Open Clinical Study
Phase N/A · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT06431100Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patient
NA · 1 location(s) · Hospital St. Joseph, Marseille, France · NCT05027321Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
Phase 1 · 2 location(s) · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd · NCT07156253Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
NA · 2 location(s) · Cooler Heads Care Inc. · NCT05484973Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia
Phase N/A · 7 location(s) · Carevive Systems, Inc. · NCT05974150Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer
NA · 2 location(s) · European University Miguel de Cervantes · NCT07467824The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Phase N/A · 1 location(s) · VastBiome · NCT05037825One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer
NA · 1 location(s) · Tata Medical Center · NCT03788213HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT06769425Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 13 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT05985655Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
NA · 1 location(s) · Jessica Di Vincenzo Sormani · NCT07171658Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for
NA · 1 location(s) · Sidekick Health · NCT06989450Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surge
Phase 2 · 4 location(s) · University of Chicago · NCT06348134Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1 · 2 location(s) · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd · NCT06666270Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
EARLY_Phase 1 · 2 location(s) · Philip Chang · NCT06123286A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT04683679Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore
NA · 4 location(s) · National Cancer Centre, Singapore · NCT07116161Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Eva
Phase 2 · 4 location(s) · M.D. Anderson Cancer Center · NCT07076485EXoPERT EMERALD Clinical Study
Phase N/A · 9 location(s) · EXoPERT · NCT07186296Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06042569Metabolism, Circadian Rhythms and Ovarian Function
Phase N/A · 1 location(s) · University Hospital, Lille · NCT05007834A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ov
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT07532434A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
Phase 1 · 7 location(s) · Light Chain Bioscience - Novimmune SA · NCT05403554SBRT in Early Breast Cancer in Elderly Women
NA · 1 location(s) · University of Rome Tor Vergata · NCT05071105Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NA · 11 location(s) · University of California, San Francisco · NCT02620852Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Phase 2 · 3 location(s) · National Cancer Institute (NCI) · NCT06195306RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Phase 1/Phase 2 · 3 location(s) · Georgetown University · NCT05256745A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Phase 1 · 4 location(s) · Cogent Biosciences, Inc. · NCT07383506
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.